Oramed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021
Cash & Equivalents	52.18	54.42	9.06	40.46	27.46	77.25
Short-Term Investments	82.51	87.51	152.99	115.26	118.82	16.9
Cash & Short-Term Investments	134.69	141.93	162.05	155.72	146.28	94.14
Cash Growth	-5.35%	-12.41%	4.06%	6.45%	55.39%	-
Prepaid Expenses	1.03	1.29	0.54	1.39	1.66	1.2
Total Current Assets	136.12	143.22	162.58	157.11	147.94	95.34
Property, Plant & Equipment	1.43	1.11	1.57	1.8	0.89	0.93
Long-Term Investments	81.86	10.91	56.37	2.7	3.88	6.69
Other Long-Term Assets	0.04	0.03	0.03	0.03	25.12	25.04
Total Assets	220.49	155.28	220.55	161.64	177.82	128
Accounts Payable	0.56	0.79	0.55	2.18	1.69	2.61
Accrued Expenses	0.82	1.48	1.38	1.97	2.31	1.2
Short-Term Debt	-	-	51.01	-	-	-
Current Portion of Leases	0.27	0.22	0.27	0.25	0.13	0.13
Current Income Taxes Payable	3.48	3.2	-	-	-	-
Current Unearned Revenue	0.99	-	-	1.34	2.7	2.7
Other Current Liabilities	-	-	-	0.01	0.53	0.04
Total Current Liabilities	6.12	5.69	53.21	5.75	7.37	6.68
Long-Term Leases	0.59	0.16	0.34	0.65	0.37	0.4
Long-Term Unearned Revenue	3.5	4	4	4	3.34	4.24
Pension & Post-Retirement Benefits	0.04	0.03	0.03	0.02	0.02	0.02
Other Long-Term Liabilities	-	0.06	0.07	0.07	0.11	0.14
Total Liabilities	18.16	9.93	57.66	10.49	11.21	11.48
Common Stock	0.49	0.48	0.49	0.48	0.46	0.42
Additional Paid-In Capital	325.37	322.4	320.89	314.42	292.51	230.2
Retained Earnings	-122.58	-176.62	-157.56	-163.08	-126.52	-114.85
Total Common Equity	203.28	146.27	163.82	151.81	166.45	115.77
Minority Interest	-0.95	-0.92	-0.93	-0.66	0.16	0.74
Shareholders' Equity	202.33	145.35	162.89	151.16	166.61	116.52
Total Liabilities & Equity	220.49	155.28	220.55	161.64	177.82	128
Total Debt	0.86	0.37	51.62	0.89	0.5	0.53
Net Cash (Debt)	133.83	141.56	112.23	154.83	149.66	100.3
Net Cash Growth	-6.10%	26.13%	-27.51%	3.45%	49.21%	-
Net Cash Per Share	3.16	3.47	2.77	3.97	4.03	3.52
Filing Date Shares Outstanding	39.8	40.85	40.52	39.78	38.56	38.09
Total Common Shares Outstanding	40.84	39.92	40.34	39.56	38.16	35.29
Working Capital	130	137.54	109.37	151.36	140.57	88.66
Book Value Per Share	4.98	3.66	4.06	3.84	4.36	3.28
Tangible Book Value	203.28	146.27	163.82	151.81	166.45	115.77
Tangible Book Value Per Share	4.98	3.66	4.06	3.84	4.36	3.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.